亚太地区精准医疗软体市场:依产品类型、应用、最终用户和国家分析和预测(2024-2033)
市场调查报告书
商品编码
1614805

亚太地区精准医疗软体市场:依产品类型、应用、最终用户和国家分析和预测(2024-2033)

Asia-Pacific Precision Medicine Software Market: Focus on Product Type, Application, End User, and Country - Analysis and Forecast 2024-2033

出版日期: | 出版商: BIS Research | 英文 51 Pages | 商品交期: 1-5个工作天内

价格

亚太地区精准医疗软体市场规模预计将从 2023 年的 3.084 亿美元增至 2033 年的 11.108 亿美元,预测期内复合年增长率为 13.74%。

主要市场统计数据
预测期 2024-2033
2024年评估 3.486 亿美元
2033年预测 11.108 亿美元
复合年增长率 13.74%

由于个人化医疗解决方案的使用增加和数位健康技术的发展,亚洲精准医疗软体市场正在快速成长。精准医学软体旨在评估和解释大量患者资料,包括遗传、生活方式和环境因素,以创建改善患者治疗效果的个人化治疗计划。这种方法对于治疗遗传性疾病、癌症和慢性病特别有用,在这些疾病中,客製化护理至关重要。

受医疗保健基础设施投资增加、鼓励个人化医疗的政府计划以及生物技术领域发展的推动,韩国、中国、日本和印度等国家正在引领市场。人工智慧、机器学习和巨量资料分析的技术发展使精密工业能够更有效地进行资料处理和决策。

由于对个人化治疗的需求不断增长以及基因组学的进步,能够处理复杂资料并提供可行见解的创新软体解决方案变得越来越必要。该地区越来越多地使用电子健康记录(EHR) 和医疗保健数位化化也推动了精准医疗软体的扩展。

随着该地区医疗保健环境的进一步发展,精准医疗软体预计将在提高治疗准确性和促进以患者为中心的护理方面发挥重要作用,并将为改善全部区域的医疗保健成果做出贡献。

市场分类:

第 1 部分:依规定格式

  • 本地
  • 云端基础

第 2 部分:按应用

  • 癌症
  • 心血管
  • 罕见疾病
  • 其他的

第 3 部分:最终用户

  • 医疗服务提供方
  • 研究中心/政府机构
  • 製药和生物技术公司
  • 其他的

第 4 部分:按地区

  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳洲
    • 其他的

本报告调查了亚太地区精准医疗软体市场,提供了行业趋势、技术和专利趋势、法律制度、市场成长促进和限制、市场规模趋势和预测、各个细分市场和主要国家等资讯。单独编制详细分析、竞争格局、主要企业简介等。

目录

执行摘要

范围和定义

第一章 市场

  • 趋势:当前和未来的影响评估
    • 个性化医疗的兴起
    • 透过云端基础的交付平台提高资料可存取性
  • 供应链概览
    • 价值链分析
  • 研究发展回顾
    • 专利申请趋势
  • 监管状况
  • 市场动态概览
    • 市场驱动因素
    • 市场限制因素
    • 市场机会

第二章 区域

  • 区域概况
  • 生长推进因素/抑制因子
  • 亚太地区
    • 区域概况
    • 市场成长的驱动因素
    • 市场问题
    • 目的
    • 产品
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国
    • 其他的

第三章市场:竞争基准化分析与公司概况

  • 下一个前沿
  • 地理评估

第四章调查方法

Product Code: BHP2458SS

Introduction to Asia-Pacific Precision Medicine Software Market

The Asia-Pacific precision medicine software market was valued at $308.4 million in 2023 and is expected to reach $1,110.8 million by 2033, growing at a CAGR of 13.74% between 2024 and 2033. Precision medicine software in the APAC market refers to cutting-edge digital tools and applications that make precision medicine easier to apply in healthcare. With this individualized approach, medical decisions and treatments are tailored to the unique characteristics of each patient, including genetics, lifestyle, environment, and particular molecular or cellular profiles.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$348.6 Million
2033 Forecast$1,110.8 Million
CAGR13.74%

The market for precision medicine software in Asia is growing quickly due to the growing use of individualized healthcare solutions and developments in digital health technologies. In order to create individualized treatment plans that enhance patient outcomes, precision medicine software is made to evaluate and interpret enormous volumes of patient data, including genetic, lifestyle, and environmental factors. This method works especially well for treating genetic disorders, cancer, and chronic illnesses where customized care is essential.

With the help of rising healthcare infrastructure investments, government programs encouraging personalized medicine, and developing biotechnology sectors, nations like South Korea, China, Japan, and India are dominating the market. More effective data processing and decision-making in the precision industry are made possible by technological developments in artificial intelligence (AI), machine learning, and big data analytics.

Innovative software solutions that can handle complex data and deliver actionable insights are becoming more and more necessary as a result of the growing demand for personalized treatments and genomics advancements. The expansion of precision medicine software is also aided by the region's increasing use of electronic health records (EHR) and the digitization of healthcare.

Precision medicine software is positioned to play a critical role in improving treatment accuracy and encouraging patient-centric care as the APAC healthcare landscape develops further, helping to improve healthcare outcomes throughout the region.

Market Segmentation:

Segmentation 1: by Delivery Mode

  • On-Premises Delivery Mode
  • Cloud-Based Delivery Mode

Segmentation 2: by Application

  • Oncology
  • Cardiovascular
  • Rare Diseases
  • Others

Segmentation 3: by End User

  • Healthcare Providers
  • Research Centers and Government Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Segmentation 4: by Region

  • Asia-Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: This report provides a comprehensive product/innovation strategy for the Asia-Pacific precision medicine software market, identifying opportunities for market entry, technology adoption, and sustainable growth. It offers actionable insights, helping organizations to meet environmental standards, gain a competitive edge, and capitalize on the increasing demand for eco-friendly solutions in various industries.

Growth/Marketing Strategy: This report offers a comprehensive growth and marketing strategy designed specifically for the Asia-Pacific precision medicine software market. It presents a targeted approach to identifying specialized market segments, establishing a competitive advantage, and implementing creative marketing initiatives aimed at optimizing market share and financial performance. By harnessing these strategic recommendations, organizations can elevate their market presence, seize emerging prospects, and efficiently propel revenue expansion.

Competitive Strategy: This report crafts a strong competitive strategy tailored to the Asia-Pacific precision medicine software market. It evaluates market rivals, suggests methods to stand out, and offers guidance for maintaining a competitive edge. By adhering to these strategic directives, companies can position themselves effectively in the face of market competition, ensuring sustained prosperity and profitability.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Rise in Personalized Healthcare
    • 1.1.2 Cloud-Based Delivery Mode-Based Platforms Elevating Data Accessibility
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics Overview
    • 1.5.1 Market Drivers
      • 1.5.1.1 Utilizing Artificial Intelligence and Precision Medicine Together
      • 1.5.1.2 Enhancement in the Precision Medicine Field Using Integrated and Automated Solutions
    • 1.5.2 Market Restraints
      • 1.5.2.1 Data Safety and Privacy Concerns
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Leveraging Electronic Health Records in the Market

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Application
    • 2.3.5 Product
    • 2.3.6 China
    • 2.3.7 India
    • 2.3.8 Australia
    • 2.3.9 Japan
    • 2.3.10 South Korea
    • 2.3.11 Rest-of-Asia-Pacific

3 Markets Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Geographic Assessment

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Precision Medicine Software Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 2: Asia-Pacific Precision Medicine Software Market (by Delivery Mode), $Million, 2023, 2027, and 2033
  • Figure 3: Asia-Pacific Precision Medicine Software Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Asia-Pacific Precision Medicine Software Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 5: Key Events of Precision Medicine Software Market, 2023 and 2024
  • Figure 6: Role of Precision Medicine Software in Personalized Care
  • Figure 7: Benefits of Using Cloud-Based Delivery Mode Technology in Healthcare
  • Figure 8: Supply Chain and Risks within the Supply Chain
  • Figure 9: Precision Medicine Software Market (by Country), January 2021-December 2023
  • Figure 10: Precision Medicine Software (by Year), January 2021-December 2023
  • Figure 11: Impact Analysis of Market Navigating Factors, 2023-2033
  • Figure 12: Benefits of Integrating AI with Precision Medicine
  • Figure 13: Two Key Strategies for Empowering Precision Medicine
  • Figure 14: China Precision Medicine Software Market, $Million, 2023-2033
  • Figure 15: India Precision Medicine Software Market, $Million, 2023-2033
  • Figure 16: Australia Precision Medicine Software Market, $Million, 2023-2033
  • Figure 17: Japan Precision Medicine Software Market, $Million, 2023-2033
  • Figure 18: South Korea Precision Medicine Software Market, $Million, 2023-2033
  • Figure 19: Rest-of-Asia-Pacific Precision Medicine Software Market, $Million, 2023-2033
  • Figure 20: Strategic Initiatives, 2021-2023
  • Figure 21: Share of Strategic Initiatives, 2021-2023
  • Figure 22: Data Triangulation
  • Figure 23: Top-Down and Bottom-Up Approach
  • Figure 24: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Precision Medicine Software Market Trend Analysis
  • Table 4: Cloud-Based Delivery Mode-Based Platform
  • Table 5: Role of EHRs in Advancing Precision Medicine
  • Table 6: Precision Medicine Software (by Region), $Million, 2023-2033
  • Table 7: Asia-Pacific Precision Medicine Software Market (by Application), $Million, 2023-2033
  • Table 8: Asia-Pacific Precision Medicine Software Market (by End User), $Million, 2023-2033
  • Table 9: Asia-Pacific Precision Medicine Software Market (by Delivery Mode), $Million, 2023-2033